No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
CN Stock MarketDetailed Quotes
600572 Zhejiang Conba Pharmaceutical
- 5.24
- +0.11+2.14%
Trading May 13 10:43 CST
13.47BMarket Cap25.69P/E (TTM)
5.24High5.08Low264.41KlotVolume5.09Open5.13Pre Close136.70MTurnover1.03%Turnover Ratio22.78P/E (Static)2.57BShares7.1252wk High1.88P/B13.43BFloat Cap4.0752wk Low5.64Limit Up2.56BShs Float12.33Historical High4.62Limit Down3.12%Amplitude-0.63Historical Low0.15Dividend TTM5.17Avg Price113.82KlotAsk2.86%Div YieldTTM100Lot Size157.29KlotBid
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Conn Bay (600572.SH): Cumulative repurchase of 51.45 million shares of the company
Glonghui, May 5, 丨 Conn Bay (600572.SH) announced that as of April 30, 2024, the company had repurchased a total of 51.46.45 million shares of the company's shares through centralized bidding transactions at the Shanghai Stock Exchange, accounting for 2.00% of the company's total share capital. The highest repurchase transaction price was 5.00 yuan/share, the lowest price was 4.08 yuan/share, and the total capital commission used was 245.9663 million yuan (excluding transaction fees such as stamp duty and transaction fees).
Conn Bay (600572.SH)'s net profit of 216 million yuan in the first quarter decreased by 23.98% year-on-year
On April 26, Ge Longhui (600572.SH) released its report for the first quarter of 2024. Operating revenue for the reporting period was 1,824 million yuan, a year-on-year decrease of 14.38%; net profit attributable to shareholders of listed companies was 216 million yuan, a year-on-year decrease of 23.98%; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 201 million yuan, a year-on-year decrease of 23.57%; and basic earnings per share were 0.084 yuan.
Conn Bay (600572.SH) announced its 2023 annual results, with net profit of 592 million yuan, an increase of 65.19%
Conn Bay (600572.SH) released its 2023 annual report. The company's revenue was 6.733 billion yuan...
Are Strong Financial Prospects The Force That Is Driving The Momentum In Zhejiang CONBA Pharmaceutical Co.,Ltd.'s SHSE:600572) Stock?
Zhejiang CONBA PharmaceuticalLtd (SHSE:600572) has had a great run on the share market with its stock up by a significant 10% over the last three months. Since the market usually pay for a company's
Conn Bay (600572.SH) has repurchased a total of 1% of its shares at a cost of 120 million yuan
Conn Bay (600572.SH) announced that as of March 29, 2024, the company passed the Shanghai Stock Exchange...
The controlling shareholders of Kangenbei (600572.SH) increased their total shares by 2%
Conn Bay (600572.SH) issued an announcement from January 31, 2024 to March 22, 2024...
Comments
Zhejiang CONBA Pharmaceutical's low P/E ratio is due to its poor earnings outlook. Shareholders accept this, anticipating no future earnings surprises. Without improvement, this will continue to hinder the share price.
Zhejiang CONBA Pharmaceutical Co.,Ltd.'s (SHSE:600572) Shares Lagging The Market But So Is The Business 1
The market's expectation for durable top line growth could explain the share price weakness. The company's performance last year may indicate unresolved challenges. Several warning signs could influence the company's future performance.
Zhejiang CONBA Pharmaceutical's cash and EBIT growth point to its good position to handle any potential debt. Its strong cash conversion indicates a sturdy financial stance.
Despite share price gain, progress may not be reflected in EPS. Recorded TSR loss of 2% per year over last five years hints at potential risks, despite promising shareholder returns.
Read more
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
%Chg